Fungizone® (Amphotericin B for injection) - Important Safety Information from Bristol-Myers Squibb Pharmaceuticals as approved by the Irish Medicines Board
28 May 2009
Important safety information communication from Bristol-Myers Squibb Pharmaceuticals on the risk of overdose due to confusion between Lipid- and Non-lipid-based Formulations of Parenteral Amphotericin B, including Fungizone® (Amphotericin B for injection)
Fungizone® (Amphotericin B for injection) - Important Safety Information